Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer

被引:90
|
作者
Wang, Xuyi [1 ,2 ]
Simpson, Evan R. [1 ,3 ]
Brown, Kristy A. [1 ,2 ]
机构
[1] Monash Univ, Metab & Canc Lab, Ctr Canc Res, Hudson Inst Med Res, Clayton, Vic, Australia
[2] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Obesity; Aromatase; Breast cancer; Adipose; Stromal cells; NECROSIS-FACTOR-ALPHA; LIVER RECEPTOR HOMOLOG-1; ADJUVANT ENDOCRINE THERAPY; PROSTAGLANDIN E-2; STROMAL CELLS; INSULIN-RESISTANCE; PROMOTER-II; HORMONE CONCENTRATIONS; PI3K/AKT/MTOR PATHWAY; EPITHELIAL-CELLS;
D O I
10.1016/j.jsbmb.2015.07.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The number of breast cancer cases has increased in the last a few decades and this is believed to be associated with the increased prevalence of obesity worldwide. The risk of breast cancer increases with age beyond menopause and the relationship between obesity and the risk of breast cancer in postmenopausal women is well established. The majority of postmenopausal breast cancers are estrogen receptor (ER) positive and estrogens produced in the adipose tissue promotes tumor formation. Obesity results in the secretion of inflammatory factors that stimulate the expression of the aromatase enzyme, which converts androgens into estrogens in the adipose tissue. Evidence demonstrating a link between obesity and breast cancer has led to the investigation of metabolic pathways as novel regulators of estrogen production, including pathways that can be targeted to inhibit aromatase specifically within the breast. This review aims to present some of the key findings in this regard. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 50 条
  • [31] Obesity and Breast Cancer: Adipose Tissue, Adipocytokines, Chronic Inflammation, and Hypoxia
    Simsir, Ilgin Yildirim
    Soyaltin, Utku Erdem
    Yilmaz, Candeger
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 22 (04) : 244 - 253
  • [32] Breast cancer, obesity and adipose tissue: a high-risk combination
    Fallone, Frederique
    Deudon, Remi
    Muller, Catherine
    Vaysse, Charlotte
    M S-MEDECINE SCIENCES, 2018, 34 (12): : 1079 - 1086
  • [33] Postmenopausal breast cancer, aromatase inhibitors, and bone health
    Heneghan, H. M.
    McKenna, M.
    Walshe, J.
    Rothwell, J.
    Evoy, D.
    Geraghty, J.
    McDermott, E.
    Prichard, R. S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 416 - 417
  • [34] Common mechanisms of dysfunctional adipose tissue and obesity-related cancers
    Matafome, P.
    Santos-Silva, D.
    Sena, C. M.
    Seica, R.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2013, 29 (04) : 285 - 295
  • [36] Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 47 - 48
  • [37] Risks and benefits of aromatase inhibitors in postmenopausal breast cancer
    Michaud, LB
    Buzdar, AU
    DRUG SAFETY, 1999, 21 (04) : 297 - 309
  • [38] Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer
    Laura Boehnke Michaud
    Aman U. Buzdar
    Drug Safety, 1999, 21 : 297 - 309
  • [39] Aromatase, breast cancer and obesity: a complex interaction
    Bulun, Serdar E.
    Chen, Dong
    Moy, Irene
    Brooks, David C.
    Zhao, Hong
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2012, 23 (02): : 83 - 89
  • [40] Obesity and breast cancer: role of inflammation and aromatase
    Simpson, Evan R.
    Brown, Kristy A.
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (03) : T51 - T59